A comprehensive review finds that aspirin does not prevent colorectal cancer, contrary to earlier hopes based on observational studies. Researchers analyzing randomized controlled trials found no protective effect from regular aspirin use against this common cancer.

The distinction matters. Observational studies suggested aspirin might reduce colorectal cancer risk, but these studies cannot prove cause-and-effect. When researchers examined randomized trials, where people take aspirin or a placebo without knowing which, the protective signal disappeared. This reflects a fundamental principle in medical research: randomized trials provide stronger evidence than observational data.

The finding doesn't mean aspirin has no health benefits. Low-dose aspirin remains recommended for some people at high risk of heart disease or stroke. But cancer prevention isn't one of those proven benefits.

So what actually helps prevent colorectal cancer? The evidence points elsewhere.

Screening remains the most effective tool. Colonoscopies catch precancerous polyps before they become tumors. The U.S. Preventive Services Task Force recommends colorectal cancer screening beginning at age 45 for average-risk adults.

Lifestyle factors matter significantly. A diet rich in fiber, whole grains, fruits, and vegetables reduces risk. Regular physical activity, maintaining a healthy weight, limiting alcohol, and avoiding smoking all contribute to lower colorectal cancer rates. These changes address multiple cancer types, not just colorectal.

People with a family history of colorectal cancer or certain genetic conditions need personalized screening plans. Lynch syndrome and familial adenomatous polyposis increase risk substantially, warranting earlier and more frequent screening.

The bottom line: aspirin isn't a shortcut to cancer prevention. Regular screening, dietary choices, and physical activity form the foundation of colorectal cancer prevention. Talk with your doctor about your individual risk factors and the right screening schedule for you.

THE BOTTOM LINE